The Miami Entrepreneur

Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales

Read Time:6 Second

The pharmaceutical giant’s quarterly results also benefitted from a smaller-than-feared drop in sales for its Covid antiviral pill Paxlovid.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Yum Brands earnings miss estimates as Pizza Hut, KFC sales disappoint
Next post Taco Bell parent Yum Brands shares slide on Q1 earnings and revenue miss